High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need.

about

High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need.

Item

http://www.wikidata.org/entity/Q38624772

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need.

@en

type

Item

label

High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need.

@en

prefLabel

High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need.

@en

P1476

High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need.

@en

P2093

Alberto Morello

http://www.w3.org/2001/XMLSchema#string

Giovanni Ciccarelli

http://www.w3.org/2001/XMLSchema#string

Michele Ciccarelli

http://www.w3.org/2001/XMLSchema#string

Paolo Golino

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis

Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients

Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib

Effect of torcetrapib on the progression of coronary atherosclerosis

Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease

Effects of torcetrapib in patients at high risk for coronary events

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms.

P304

29-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giovanni Cimmino

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26535185

http://www.w3.org/2001/XMLSchema#string

P932

4592041

http://www.w3.org/2001/XMLSchema#string